Compare TNET & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNET | TNDM |
|---|---|---|
| Founded | 1988 | 2006 |
| Country | United States | United States |
| Employees | 2700 | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2000 | 2013 |
| Metric | TNET | TNDM |
|---|---|---|
| Price | $38.89 | $20.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 19 |
| Target Price | ★ $65.80 | $28.16 |
| AVG Volume (30 Days) | 385.1K | ★ 1.6M |
| Earning Date | 04-24-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.20 | N/A |
| Revenue | ★ $5,010,000,000.00 | $1,014,736,000.00 |
| Revenue This Year | N/A | $8.11 |
| Revenue Next Year | $3.30 | $12.03 |
| P/E Ratio | $11.98 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $33.67 | $10.00 |
| 52 Week High | $88.56 | $29.65 |
| Indicator | TNET | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 54.21 | 45.95 |
| Support Level | $34.55 | $19.70 |
| Resistance Level | $39.22 | $21.54 |
| Average True Range (ATR) | 1.72 | 1.28 |
| MACD | 0.51 | 0.07 |
| Stochastic Oscillator | 86.64 | 42.13 |
Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.